Kovack Advisors’s Xylem XYL Stock Holding History

Kovack Advisors’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,750	Closed	-$210K	–	763
2021 Q2	$210K	Buy	+1,750	New	+$200K	0.02%	629

Other funds holding XYL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Kovack Advisors's XYL Position: Q3 2021 in Review

Kovack Advisors sold out of Xylem (XYL) in Q3 2021, closing a stake of 1,750 shares — an estimated $210K sold.

Kovack Advisors first reported a position in XYL in Q2 2021 and held it in 1 quarter. The position peaked at $210K in Q2 2021. 783 funds tracked by Wall St. Rank hold XYL as of Q3 2021.

Kovack Advisors reported no remaining Xylem position as of Q3 2021 after selling out during the quarter.
Kovack Advisors sold 1,750 Xylem shares in Q3 2021, an estimated $210K.
Kovack Advisors first reported a position in Xylem in Q2 2021 and held it in 1 quarter.
Kovack Advisors's Xylem position peaked at $210K in Q2 2021.
783 funds tracked by Wall St. Rank held Xylem as of Q3 2021.

Based on Kovack Advisors's 13F filing for Q3 2021, filed 3 Nov 2021.